| Action | Date | Index | Provider |
|---|---|---|---|
| Join | 2020 | Health Care & Pharmaceuticals | Egyptian Exchange |
| Leave | 2010 | EGX 70 | Egyptian Exchange |
| Join | 2010 | EGX 70 | Egyptian Exchange |
| Join | 1996 | Egyptian Exchange |
| Cairo Pharmaceuticals |
| 4 Abdel Hamid Al-Dib St., Victoria Square, Shubra |
| T : +20 2 22022459 |
| F : +20 2 22025477 |
| www.kahirapharma.net |
| kahira.info@kahirapharmaeg.com |
| Title | Name | As Of |
|---|---|---|
| Chairman: | Tariq Salman | |
| Managing Director: | Bassem Salah | |
| Board Member: | Ahmed El Doseky | 2023 |
| Maha Arafa | 2023 | |
| Ahmed Abu Hendia | 2024 | |
| Yousra Al Qassas |
| Date | Title | File |
|---|---|---|
| 2025 | Cairo Pharmaceuticals Annual Financials Report 2025 | |
| 2025 | Cairo Pharmaceuticals Quarterly Financials Report Q1 2025 | |
| 2025 | Cairo Pharmaceuticals Quarterly Financials Report Q2 2025 | |
| 2025 | Kahira Pharmaceuticals Quarterly Financials Report Q1 2025 | |
| 2024 | Kahira Pharmaceuticals Annual Financials Report 2024 | |
| 2024 | Kahira Pharmaceuticals Quarterly Financials Report Q3 2024 | |
| 2023 | Kahira Pharmaceuticals Quarterly Financials Report Q1 2024 | |
| 2023 | Kahira Pharmaceuticals Annual Financials Report 2023 | |
| 2023 | Kahira Pharmaceuticals Quarterly Financials Report Q3 2023 | |
| 2023 | Kahira Pharmaceuticals Annual Financials Report 2022 | |
| 2022 | Kahira Pharmaceuticals Quarterly Financials Report Q1 2023 |